Perbedaan Organon Pharma Indonesia Tbk. dan Soho Global Health Tbk: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Soho Global Health Tbk diperdagangkan di Rp1.605 (kapitalisasi pasar 20,81 T, volume 24 jam 177,2 rb). Perbedaan utamanya: Soho Global Health Tbk jauh lebih besar — sekitar 199,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SOHO | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 20,81 T |
Volume | — | 177,2 rb |
Lot | — | 1,77 rb |
Perputaran | — | 282,73 jt |
Harga Rata-rata | — | 1.595,54 |
Nilai Transaksi | — | 282,73 jt |
Harga Ekuilibrium Indikatif | — | 1.605 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Soho Global Health Tbk (the Company), was established in Jakarta based on Notarial Deed No. 116 of Elisa Pondaag, S.H., dated August 27, 1956 under the name of PT Parit Padang. The Company started its commercial activitiesin 1956.
Selengkapnya di halaman SOHO →